Effect of curcumin on cardiopulmonary efficacy
Phase 2
- Conditions
- central obesity.Overweight and obesity
- Registration Number
- IRCT20210413050958N6
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Signed informed consent form
Aged 18-65 years old
Subjects with central obesity based on NCEP-ATP III guidelines
Exclusion Criteria
History of systemic diseases
History of cardiac ischemia
Pregnancy
Breastfeeding
Hepatic failure
Biliary obstruction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Maximal oxygen consumption (V?O2max). Timepoint: Before the intervention and 8 weeks after taking supplement or placebo. Method of measurement: cardiopulmonary exercise testing.
- Secondary Outcome Measures
Name Time Method